Sohini Das

Pharmaceutical companies have urged the government to revise prices of cisplatin and carboplatin as soaring platinum costs and raw material constraints disrupt supplies

Oncology drugmaker says soaring platinum prices, higher import duties and lengthy import approvals have made production financially unviable, worsening shortages of key chemotherapy medicines

Expands focus beyond tractors into harvesters, seed drills and telematics-led services

Iveco seen as technology and global expansion platform; EVs and hydrogen remain central to future strategy

Tata Motors chairman says the commercial vehicles business is poised for growth after the demerger, with technology, innovation and global expansion driving strategy

The two-year programme aims to replace over 2 lakh ageing trucks and buses across Delhi-NCR through interest subsidies, tax waivers and manufacturer discounts

The tyre maker expects tracks and developed markets such as North America and Europe to power growth as access to additional CAMSO categories expands

Novel antibiotic to be launched in India around the same time; company to commercialise product on its own in US

Maruti Suzuki reports a sharp rebound in mini-car sales as production constraints ease, while rising fuel prices drive stronger demand for CNG-powered vehicles

Nearly three in 10 luxury vehicles sold in India are sedans, with Audi, BMW and Mercedes-Benz each deriving about 40 per cent of India sales from the body style

The team put together by the firm's founder may be just what the next decade demands

Boston-headquartered MedTherapy Biotech is expanding its India manufacturing footprint while preparing clinical trials for a lymphoma-focused CAR-T therapy with Cipla

Crisil states 22 of the 34 sectors stress-tested could see operating profitability decline by over 10 per cent as companies may not be able to fully pass on higher costs to consumers immediately

Firms diversify sourcing, redraw playbook, increase prices to tide over crisis

Indian pharmaceutical companies are investing in specialty drugs, biosimilars and local manufacturing in the US despite a near 10 per cent fall in exports in FY26

Petrol, diesel have seen cumulative hike of ₹5 per litre in May

Max hospitals, Indraprastha among chains involved in series of 12 orders

NephroPlus said overseas markets now contribute nearly 42 per cent of revenue as the dialysis provider expands globally through acquisitions, PPP projects and clinic additions

India's overall MedTech opportunity could expand more than fourfold to $83-89 billion by 2035, driven by rising domestic demand, exports and contract manufacturing

Auto companies have not cut back on capex and are planning new launches, even as they remain cautious about margins amid input costs and supply-chain risks